Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years

Sullivan, Eoin P.; Dinneen, Sean F.
December 2008
ACP Journal Club;12/16/2008, Vol. 149 Issue 6, p2
Academic Journal
The article provides information on the benefits of early intensive glucose control in preventing diabetes-related complications. In the study, 4209 patients 25 to 65 years of age, who had been newly diagnosed type 2 diabetes and fasting plasma glucose levels after 3 months of dietary therapy, were examined. It shows the results for intensive glucose control with a sulfonylurea or insulin. Groups did not differ for stroke or peripheral vascular disease.


Related Articles

  • The multi-talented podocyte. Fogo, Agnes B. // Nephrology Dialysis Transplantation;Nov2009, Vol. 24 Issue 11, p3269 

    The article reports on a study focusing on the qualities of podocyte cell and its role in the development of diabetic nephropathy. As reported, podocyte was recognized as a key element of the capillary wall barrier to maintain normal permeability and has a very limiting regeneration capacity....

  • Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery. Renard, Eric; Place, Jerome; Cantwell, Martin; Chevassus, Hugues; Palerm, Cesar C. // Diabetes Care;Jan2010, Vol. 33 Issue 1, p121 

    OBJECTIVE -- Attempts to build an artificial pancreas by using subcutaneous insulin delivery from a portable pump guided by an subcutaneous glucose sensor have encountered delays and variability of insulin absorption. We tested closed-loop intraperitoneal insulin infusion from an implanted pump...

  • β-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes. Matveyenko, Aleksey V.; Butler, Peter C. // Diabetes;Jul2006, Vol. 55 Issue 7, p2106 

    Type 2 diabetes is characterized by defects in insulin secretion and action and is preceded by impaired fasting glucose (IFG). The islet anatomy in IFG and type 2 diabetes reveals an ∼50 and 65% deficit in β-cell mass, with increased β-cell apoptosis and islet amyloid derived from...

  • Nocturnal Glucose Control and Free Insulin Levels in Children With Type 1 Diabetes by Use of the Long-Acting Insulin HOE 901 as Part of a Three-Injection Regimen. Mohn, Angelika; Strang, Sally; Wernicke-Panten, Karin; Lang, Anna M.; Edge, Julie A.; Dunger, David B. // Diabetes Care;Apr2000, Vol. 23 Issue 4, p557 

    Presents a study which examined nocturnal glucose control and free insulin levels in children with type 1 diabetes. Comparison from subjects given NPH insulin; Data of the study; Indications of the data.

  • Measurement of Insulin Sensitivity in Children. Schwartz, Betsy; Jacobs Jr., David R.; Moran, Antoinette; Steinberger, Julia; Hong, Ching-Ping; Sinaiko, Alan R. // Diabetes Care;Apr2008, Vol. 31 Issue 4, p783 

    OBJECTIVE -- In this study we compared fasting insulin and measures of insulin sensitivity (M) based on fasting insulin and glucose (i.e., homeostasis model assessment [HOMA], quantitative insulin sensitivity check index [QUICKI], and fasting glucose-to-insulin ratio [FGIR]) or triglycerides to...

  • Prolonged Nocturnal Hypoglycemia Is Common During 12 Months of Continuous Glucose Monitoring in Children and Adults With Type 1 Diabetes.  // Diabetes Care;May2010, Vol. 33 Issue 5, p1004 

    OBJECTIVE -- To characterize the amount of nocturnal hypoglycemia and evaluate factors associated with nocturnal hypoglycemia assessed with continuous glucose monitoring (CGM) in adults and children with type 1 diabetes who participated in the Juvenile Diabetes Research Foundation CGM...

  • Glucagon as a Critical Factor in the Pathology of Diabetes. Edgerton, Dale S.; Cherrington, Alan D. // Diabetes;Feb2011, Vol. 60 Issue 2, p377 

    The article discusses the potential role of glucagon in the development of diabetic hyperglycemia. It notes that there is a link between increased levels of gut derived glucagon and the severity of the diabetic phenotype. According to a 2011 study, the inhibitory effects of glucagon on hepatic...

  • Central insulin action regulates peripheral glucose and fat metabolism in mice. Koch, Linda; Wunderlich, F. Thomas; Seibler, Jost; Könner, A. Christine; Hampel, Brigitte; Irlenbusch, Sigrid; Brabant, Georg; Kahn, C. Ronald; Schwenk, Frieder; Brüning, Jens C. // Journal of Clinical Investigation;Jun2008, Vol. 118 Issue 6, p2132 

    Insulin resistance is a hallmark of type 2 diabetes, and many insights into the functions of insulin have been gained through the study of mice lacking the IR. To gain a better understanding of the role of insulin action in the brain versus peripheral tissues, we created 2 mouse models with...

  • Evaluation of Polarographic Measurements of Basal Muscle Oxygen Tension in Type I Diabetic Patients. Maisch, Christine; Hofmann, Valerie; Benda, Norbert; Luft, Dieter // Angiology;Mar1998, Vol. 49 Issue 3, p203 

    Microcirculatory changes occur early in insulin-dependent diabetes mellitus (IDDM) and are believed to be an early feature of late diabetic complications, leading to reduced oxygen pressure and hypoxia in the skin and other tissues. Whether muscle oxygen supply is also altered is unknown....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics